IDEAYA Biosciences Inc. (IDYA)
NASDAQ: IDYA
· Real-Time Price · USD
24.33
-0.04 (-0.16%)
At close: Aug 15, 2025, 3:59 PM
24.33
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
IDEAYA Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 7M | 7M | 7M | 3.92M | 11.96M | 15.51M | 23.39M | 23.48M | 45.15M | 47.45M | 50.93M | 49.87M | 29.15M | 32.05M | 27.94M | 35.55M | 35.54M | 26.79M |
Cost of Revenue | 643K | 1.74M | 2.82M | 3.2M | 4.19M | 4.09M | 3.97M | 3.5M | 3.44M | 3.65M | 3.15M | 3.02M | 17.6M | 31.37M | 42.47M | 54.1M | 48.62M | 42.24M |
Gross Profit | 6.36M | 5.26M | 4.18M | 720K | 7.77M | 11.41M | 19.42M | 19.98M | 41.7M | 43.8M | 47.78M | 46.85M | 11.55M | 683K | -14.53M | -18.55M | -13.08M | -15.45M |
Operating Income | -384.23M | -360.35M | -326.98M | -224.75M | -191.38M | -159.17M | -134.43M | -118.96M | -84.77M | -74.56M | -62.5M | -54.43M | -66.8M | -55.35M | -50.27M | -37.18M | -30.46M | -32M |
Interest Income | 41.11M | 53.26M | 52.5M | 46.63M | 37.65M | 30.28M | 21.47M | 15.75M | 10.62M | 6.28M | 3.85M | 1.76M | 938K | 599K | 506K | 494K | 433K | 528K |
Pretax Income | -331.03M | -306.31M | -274.48M | -178.12M | -153.74M | -128.89M | -112.96M | -103.21M | -74.15M | -68.28M | -60.75M | -54.76M | -67.95M | -56.85M | -49.76M | -36.69M | -30.03M | -31.47M |
Net Income | -331.03M | -306.31M | -274.48M | -178.12M | -153.74M | -128.89M | -109.36M | -97.37M | -67.36M | -61.04M | -58.99M | -55.24M | -69.4M | -58.73M | -49.76M | -36.69M | -30.03M | -31.47M |
Selling & General & Admin | 48.78M | 43.5M | 38.2M | 34.32M | 32.44M | 30.22M | 28.31M | 26.99M | 25.79M | 24.27M | 23.9M | 23.37M | 21.89M | 21.16M | 20.05M | 18.63M | 17.38M | 16.55M |
Research & Development | 342.45M | 322.75M | 294.67M | 193.26M | 169.81M | 144.45M | 129.51M | 115.45M | 104.12M | 97.74M | 89.54M | 80.93M | 74.06M | 66.25M | 58.16M | 54.1M | 48.62M | 42.24M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.42M | -4.42M | -4.42M | -4.42M | n/a | n/a | n/a |
Operating Expenses | 391.23M | 366.25M | 332.88M | 227.58M | 202.25M | 174.67M | 157.81M | 142.44M | 129.92M | 122.01M | 113.43M | 104.3M | 95.95M | 87.41M | 78.21M | 72.73M | 66M | 58.79M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -1.1M | -1.1M | -1.1M | -1.1M | -1K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 302.42M | 367.35M | 333.98M | 228.68M | 203.35M | 174.67M | 157.81M | 142.44M | 129.92M | 122.01M | 113.43M | 104.3M | 95.95M | 87.41M | 78.21M | 72.73M | 66M | 58.79M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -3.6M | -5.84M | -6.8M | -7.24M | -1.75M | 487K | 1.44M | 1.93M | 44K | 44K | 44K | n/a |
Shares Outstanding (Basic) | 88.47M | 88.36M | 87.34M | 86.19M | 77.96M | 75.11M | 65.25M | 60M | 56.25M | 48.37M | 48.13M | 40.3M | 38.66M | 38.59M | 38.36M | 37.36M | 32.85M | 31.76M |
Shares Outstanding (Diluted) | 88.47M | 88.36M | 87.34M | 86.19M | 77.96M | 75.11M | 65.25M | 60M | 56.25M | 48.37M | 48.13M | 41.11M | 38.66M | 38.59M | 38.5M | 37.77M | 32.85M | 31.76M |
EPS (Basic) | -3.79 | -3.59 | -3.3 | -2.33 | -2.19 | -2.01 | -1.89 | -1.83 | -1.31 | -1.37 | -1.43 | -1.44 | -1.81 | -1.58 | -1.39 | -1.1 | -0.96 | -1.22 |
EPS (Diluted) | -3.79 | -3.59 | -3.3 | -2.33 | -2.19 | -2.01 | -1.89 | -1.83 | -1.31 | -1.37 | -1.43 | -1.44 | -1.81 | -1.58 | -1.39 | -1.1 | -0.96 | -1.22 |
EBITDA | -382.45M | -357.95M | -325.09M | -222.89M | -188.88M | -156.66M | -131.96M | -116.55M | -82.08M | -71.63M | -59.7M | -51.6M | -64.44M | -53.41M | -48.41M | -35.54M | -28.93M | -30.57M |
EBIT | -372.91M | -360.35M | -326.98M | -224.75M | -191.39M | -159.17M | -134.43M | -118.96M | -84.77M | -74.56M | -62.5M | -54.43M | -66.8M | -55.35M | -50.27M | -37.18M | -30.46M | -32M |
Depreciation & Amortization | 2.79M | 3.88M | 3.83M | 4.21M | 4.19M | 4.09M | 3.97M | 3.5M | 3.44M | 3.65M | 3.15M | 3.02M | 2.59M | 1.79M | 1.71M | 1.64M | 1.49M | 1.43M |